The phase 3 trial is evaluating the long-term effects of sibeprenlimab-szsi on kidney function in adults with primary immunoglobulin A nephropathy.

The over-the-counter softgels are used to relieve pressure, bloating, and fullness by rapidly breaking up gas bubbles in the ...

Zaynich is a combination of cefepime, a cephalosporin antibacterial, and zidebactam, a beta-lactamase inhibitor and non-beta-lactam antibacterial.

A phase 2 trial is investigating MTX-001, an injectable regenerative therapy, for patients with noninfected venous leg ulcers.

Ranluspec is the only interchangeable ranibizumab biosimilar approved in both vial and prefilled syringe presentations.

Top food researchers have teamed up on a special issue of the American Journal of Public Health to push policymakers for stricter action on ultra-processed food ...

At Michigan schools where only 30% to 40% of students are now vaccinated, it is “simply not possible to keep diseases like measles at bay." ...

Children with fall birthdays more likely to be vaccinated, less likely to be diagnosed with influenza than those with summer birthdays.

The combination regimen significantly improved progression-free survival and objective response rates in patients who were intolerant to or failed prior imatinib therapy ...

Clinically meaningful improvements seen in overall, progression-free survival for those with RAS G12 mutation, overall population.

"Most adults covered by Medicaid are already working, caregiving or would not be subject to this policy due to illness or disability," said ACP President Dr Jan Carney.

Increased T-cell receptor clonality and novel clonotypes seen with intismeran plus pembrolizumab versus pembrolizumab alone.